S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ObsEvaOncoSec MedicalCorbus PharmaceuticalsNeuBase TherapeuticsAssembly Biosciences
SymbolNASDAQ:OBSVNASDAQ:ONCSNASDAQ:CRBPNASDAQ:NBSENASDAQ:ASMB
Price Information
Current Price$3.90$5.50$2.18$9.48$5.08
52 Week RangeHoldBuyHoldBuyBuy
MarketRank™
Overall Score1.41.61.71.31.6
Analysis Score3.23.53.23.53.4
Community Score2.32.23.03.02.3
Dividend Score0.00.00.00.00.0
Ownership Score0.81.71.70.01.7
Earnings & Valuation Score0.60.60.60.00.6
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyBuy
Consensus Price Target$11.80$7.38$26.39$17.50$29.00
% Upside from Price Target202.56% upside34.09% upside1,110.50% upside84.60% upside470.87% upside
Trade Information
Market Cap$187.20 million$153.95 million$183.20 million$219.75 million$167.75 million
Beta0.992.642.140.410.61
Average Volume9,129,164355,40220,041,262376,6751,331,807
Sales & Book Value
Annual RevenueN/AN/A$36.14 millionN/A$15.96 million
Price / SalesN/AN/A5.07N/A10.51
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.01 per share$0.60 per share$0.10 per share$1.35 per share$10.49 per share
Price / BookN/AN/A21.80N/A0.48
Profitability
Net Income$-108,790,000.00$-42,250,000.00$-71,450,000.00$-17,390,000.00$-97,630,000.00
EPS($2.49)($2.56)($1.12)($0.89)($3.72)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-2,208.06%N/A-60.14%
Return on Equity (ROE)-256.23%-332.61%-485.45%-90.43%-18.75%
Return on Assets (ROA)-93.21%-148.97%-167.68%-77.20%-15.89%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.14%0.04%0.61%N/AN/A
Current Ratio2.06%2.41%2.06%10.42%14.66%
Quick Ratio2.06%2.41%2.06%10.42%14.66%
Ownership Information
Institutional Ownership Percentage52.74%4.15%67.13%28.98%92.23%
Insider Ownership PercentageN/A0.71%8.20%24.00%7.10%
Miscellaneous
Employees534214115140
Shares Outstanding48.00 million27.99 million84.04 million23.18 million33.02 million
Next Earnings Date3/4/2021 (Estimated)3/12/2021 (Estimated)3/11/2021 (Estimated)5/13/2021 (Estimated)5/6/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.